首页> 外文OA文献 >Exploring glycosuria as a mechanism for weight and fat mass reduction. A pilot study with remogliflozin etabonate and sergliflozin etabonate in healthy obese subjects

【2h】

Exploring glycosuria as a mechanism for weight and fat mass reduction. A pilot study with remogliflozin etabonate and sergliflozin etabonate in healthy obese subjects

机译：探索糖尿作为减轻体重和脂肪量的一种机制。依托格列净和依格列净在健康肥胖者中的初步研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Napolitano Antonella; Miller Sam; Murgatroyd Peter R.; Hussey Elizabeth; Dobbins Robert L.; Bullmore Edward T.; Nunez Derek J.R.;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Exploring glycosuria as a mechanism for weight and fat mass reduction. A pilot study with remogliflozin etabonate and sergliflozin etabonate in healthy obese subjects [J] . Antonella Napolitano, Sam Miller, Peter R. Murgatroyd, Journal of Clinical & Translational Endocrinology . 2014,第1期

机译：探索糖尿作为减轻体重和脂肪量的一种机制。依托格列净和依格列净在健康肥胖者中的初步研究
2. Multiple-dose pharmacokinetics and pharmacodynamics of sergliflozin etabonate, a novel inhibitor of glucose reabsorption, in healthy overweight and obese subjects: a randomized double-blind study. [J] . Hussey EK, Dobbins RL, Stoltz RR, The Journal of Clinical Pharmacology: Official Journal of the American College of Clinical Pharmacology . 2010,第6期

机译：Sergliflozin etabonate（一种新型的葡萄糖重吸收抑制剂）在健康超重和肥胖受试者中的多剂量药代动力学和药效学：一项随机双盲研究。
3. An Open-Label, Single-Period, Two-Stage, Single Oral Dose Pharmacokinetic Study of Remogliflozin Etabonate Tablet 100 and 250 mg in Healthy Asian Indian Male Subjects Under Fasting and Fed Conditions [J] . Shashank Joshi, Girish Gudi, Vinu C. A. Menon, Clinical pharmacokinetics . 2020,第3期

机译：在禁食和美联储条件下，在禁食和喂养条件下，在禁食和喂养条件下，葡萄球菌葡萄球菌片剂100和250毫克250毫克的开放标签，单期，两阶段，口服剂量药代动力学研究
4. Finite Element Study of Skin and Fat Delineation in an Obese Subject for Transcranial Direct Current Stimulation [C] . Dennis Q. Truong, Greta Magerowski, Alvaro Pascual-Leone, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2012

机译：有限元研究肥胖对血管直流刺激的肥胖主体中的脂肪描绘
5. 選択的SGLT2阻害薬Sergliflozin etabonate及びRemogliflozin etabonateの効率的合成法の研究 [D] . 小林雅周 2019

机译：选择性SGLT2抑制剂依替格列酮和依替莫列净的有效合成方法研究。
6. Exploring glycosuria as a mechanism for weight and fat mass reduction. A pilot study with remogliflozin etabonate and sergliflozin etabonate in healthy obese subjects [O] . Antonella Napolitano, Sam Miller, Peter R. Murgatroyd, 2014

机译：探索糖尿作为减轻体重和脂肪量的一种机制。依托格列净和依格列净在健康肥胖者中的初步研究
7. Exploring glycosuria as a mechanism for weight and fat mass reduction. A pilot study with remogliflozin etabonate and sergliflozin etabonate in healthy obese subjects [O] . Antonella Napolitano, Sam Miller, Peter R. Murgatroyd, 2014

机译：探索糖尿作为减轻体重和减少脂肪量的机制。一项针对健康肥胖受试者的瑞格列净依碳酸盐和依格列酮塞格列净的初步研究

Exploring glycosuria as a mechanism for weight and fat mass reduction. A pilot study with remogliflozin etabonate and sergliflozin etabonate in healthy obese subjects

著录项

引文网络

相似文献

相关主题

期刊订阅